Bioresorbable scaffolds: focus on vascular response and long-term safety

Area of Science:

• Interventional Cardiology
• Biomaterials Science
• Vascular Biology

Background:

• Bioresorbable vascular scaffolds (BVS) represent a significant advancement over traditional drug-eluting stents (DES).
• BVS aim to address limitations of DES by promoting natural vascular healing through 'vascular restoration therapy'.
• Initial real-world data indicate feasibility of BVS implantation in a broad spectrum of patient risk profiles and lesion complexities.

Purpose of the Study:

• To evaluate the potential advantages of Bioresorbable vascular scaffolds (BVS) in Interventional Cardiology.
• To assess the feasibility and safety of BVS in diverse clinical scenarios.
• To compare the long-term outcomes of BVS against current best-in-class drug-eluting stents (DES).

Main Methods:

• Analysis of emerging data from real-world expanded use registries of BVS.
• Evaluation of patient populations ranging from low- to high-risk.
• Assessment of lesion complexity from simple to complex interventions.

Main Results:

• BVS implantation is feasible in a wide variety of patients and lesions.
• Initial experiences have highlighted some safety concerns associated with currently available BVS.
• Large-scale randomized controlled trials are underway to provide definitive data.

Conclusions:

• BVS hold promise as the next generation of coronary implants, potentially offering superior vascular healing.
• Further evidence from large randomized trials is necessary to establish the definitive safety and efficacy profile of BVS compared to DES.
• The long-term clinical impact of BVS hinges on addressing identified safety concerns and demonstrating improved patient outcomes.